SILVAGNI, Ettore
 Distribuzione geografica
Continente #
NA - Nord America 4.407
AS - Asia 3.304
EU - Europa 1.461
SA - Sud America 480
AF - Africa 289
Continente sconosciuto - Info sul continente non disponibili 206
OC - Oceania 31
AN - Antartide 1
Totale 10.179
Nazione #
US - Stati Uniti d'America 4.172
SG - Singapore 1.030
IT - Italia 615
CN - Cina 556
VN - Vietnam 292
BR - Brasile 273
BD - Bangladesh 241
HK - Hong Kong 228
ID - Indonesia 163
DE - Germania 160
GB - Regno Unito 159
IN - India 159
EG - Egitto 157
JP - Giappone 127
FR - Francia 108
CA - Canada 102
IQ - Iraq 97
MX - Messico 91
FI - Finlandia 82
TR - Turchia 70
NL - Olanda 55
EC - Ecuador 54
RU - Federazione Russa 52
PK - Pakistan 47
PH - Filippine 44
IR - Iran 43
ZA - Sudafrica 42
AR - Argentina 40
PL - Polonia 38
SA - Arabia Saudita 38
MY - Malesia 30
AU - Australia 29
CO - Colombia 29
ES - Italia 28
TW - Taiwan 28
KR - Corea 27
UA - Ucraina 27
PE - Perù 26
AT - Austria 22
BO - Bolivia 19
KE - Kenya 18
SE - Svezia 18
CL - Cile 15
VE - Venezuela 15
CH - Svizzera 13
CZ - Repubblica Ceca 12
NG - Nigeria 12
BE - Belgio 11
DZ - Algeria 11
MA - Marocco 11
JM - Giamaica 10
JO - Giordania 10
HU - Ungheria 9
LY - Libia 9
RO - Romania 8
IE - Irlanda 7
IL - Israele 7
PS - Palestinian Territory 7
TN - Tunisia 7
CR - Costa Rica 6
HN - Honduras 6
KZ - Kazakistan 6
NP - Nepal 6
AE - Emirati Arabi Uniti 5
GR - Grecia 5
LB - Libano 5
LT - Lituania 5
OM - Oman 5
TH - Thailandia 5
UY - Uruguay 5
UZ - Uzbekistan 5
AL - Albania 4
DK - Danimarca 4
ET - Etiopia 4
LV - Lettonia 4
MG - Madagascar 4
PA - Panama 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
LK - Sri Lanka 3
MM - Myanmar 3
PR - Porto Rico 3
PT - Portogallo 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
VC - Saint Vincent e Grenadine 3
BF - Burkina Faso 2
BG - Bulgaria 2
CY - Cipro 2
GE - Georgia 2
KG - Kirghizistan 2
KH - Cambogia 2
LS - Lesotho 2
NZ - Nuova Zelanda 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TG - Togo 2
UG - Uganda 2
AQ - Antartide 1
BH - Bahrain 1
Totale 9.952
Città #
Ashburn 633
Singapore 621
San Jose 468
Dallas 372
Santa Clara 256
Council Bluffs 249
Hong Kong 205
Beijing 197
Los Angeles 137
Fairfield 108
Chandler 103
Ho Chi Minh City 102
New York 102
Tokyo 99
Jakarta 85
Hanoi 74
Woodbridge 65
Houston 53
Alexandria 52
Helsinki 52
Lauterbourg 52
Seattle 50
Milan 47
Ferrara 46
Baghdad 45
Cairo 45
Buffalo 40
Wilmington 40
Chicago 39
Shanghai 39
Cambridge 37
Mexico City 35
Bologna 34
London 34
Munich 34
Rome 34
Toronto 34
Ann Arbor 33
Orem 33
Warsaw 33
Montreal 32
São Paulo 32
Atlanta 30
Princeton 28
Frankfurt am Main 24
Hefei 24
Brooklyn 23
Naples 22
Lappeenranta 21
Boston 20
Jacksonville 20
Phoenix 20
Denver 19
Poplar 19
Falkenstein 18
Izmir 18
Johannesburg 18
Manchester 18
Nanjing 18
San Francisco 18
Da Nang 17
Quito 17
Lima 16
Kuala Lumpur 15
Najaf 15
Sydney 15
Ankara 14
Chennai 14
Nairobi 14
San Diego 14
Athens 13
Miami 13
New Delhi 13
Nuremberg 13
Padova 13
Riyadh 13
Amsterdam 12
Haiphong 12
Lahore 12
Mumbai 12
Secaucus 12
Charlotte 11
City of London 11
Cuenca 11
Guayaquil 11
La Paz 11
Stockholm 11
Cincinnati 10
Columbus 10
Delhi 10
Hillah 10
Melbourne 10
Moscow 10
Rio de Janeiro 10
Surabaya 10
Tanta 10
The Dalles 10
Vienna 10
Budapest 9
Dhaka 9
Totale 5.742
Nome #
Systemic lupus erythematosus: one year in review 2023 976
Peripheral nervous system involvement in systemic lupus erythematosus: a review of the evidence 449
Novel insights into the management of rheumatoid arthritis: one year in review 2022 299
The diagnosis and clinical management of the neuropsychiatric manifestations of lupus 288
Novel insights into the management of rheumatoid arthritis: one year in review 2023 277
Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis 263
Combination of clinical factors predicts successful glucocorticoid withdrawal in systemic lupus erythematosus (SLE): results from a multicentre, retrospective cohort study 248
Biological and synthetic target DMARDs in psoriatic arthritis 212
Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases 205
From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis 200
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus 196
High-grade synovitis associates with clinical markers and response to therapy in chronic inflammatory arthritis: post hoc analysis of a synovial biomarkers prospective cohort study 195
Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome 184
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology 184
Optimizing Patient Care: A Systematic Review of Multidisciplinary Approaches for SLE Management 183
Influence of aromatase inhibitors therapy on the occurrence of rheumatoid arthritis in women with breast cancer: results from a large population-based study of the Italian Society for Rheumatology 183
Systemic lupus erythematosus: one year in review 2024 180
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 168
Therapeutic Strategies and Outcomes in Neuropsychiatric Systemic Lupus Erythematosus: An International Multicenter Retrospective Study 164
Longitudinal changes in cerebral white matter microstructure in newly diagnosed systemic lupus erythematosus patients 162
Comparison of the risks of hospitalisation for cardiovascular events in patients with rheumatoid arthritis treated with tocilizumab and etanercept 161
Focus on Sex and Gender: What We Need to Know in the Management of Rheumatoid Arthritis 160
Evaluation of the Synovial Effects of Biological and Targeted Synthetic DMARDs in Patients with Psoriatic Arthritis: A Systematic Literature Review and Meta-Analysis 157
Tofacitinib restores psoriatic arthritis fibroblast-like synoviocytes function via autophagy and mitochondrial quality control modulation 156
Adherence of Italian rheumatologists to the EULAR recommendations and outcomes in early rheumatoid arthritis patients after starting conventional DMARDs: Methotrexate in Italian patients wiTh Rheumatoid Arthritis (the MITRA study). A cohort study of the Italian Society for Rheumatology 154
Cerebrospinal Fluid Analysis in Rheumatological Diseases with Neuropsychiatric Complications and Manifestations: A Narrative Review 154
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression 151
Features associated with different inflammatory phenotypes of calcium pyrophosphate deposition (CPPD) disease: study using data from the international ACR/EULAR CPPD classification criteria cohort 148
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 148
One year in review 2018: novelties in the treatment of rheumatoid arthritis 146
Conventional brain magnetic resonance imaging in the longitudinal evaluation of newly diagnosed systemic lupus erythematosus patients: a retrospective analysis from a single-centre cohort 146
Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles 145
Clinical application of synovial biopsy in noninflammatory and persistent inflammatory refractory rheumatoid arthritis 139
Serum Antibodies Against the Oncogenic Merkel Cell Polyomavirus Detected by an Innovative Immunological Assay With Mimotopes in Healthy Subjects 139
Tofacitinib improves mitochondrial function in psoriatic arthritis fibroblast-like synoviocytes via autophagy modulation 138
Neurologic Involvement in Rheumatic Diseases 137
Methotrexate in Italian patients wiTh Rheumatoid Arthritis (MITRA study): an observational study about the use of methotrexate in early RA patients and the adherence to the EULAR 2013 recommendations. A project of the Italian Society for Rheumatology 137
Cerebral Microstructure Analysis by Diffusion-Based MRI in Systemic Lupus Erythematosus: Lessons Learned and Research Directions 133
Can conventional brain MRI support the attribution process in neuropsychiatric SLE? A multicentre retrospective study 125
Relevant domains and outcome measurement instruments in neuropsychiatric systemic lupus erythematosus: a systematic literature review 125
Systemic lupus erythematosus: one year in review 2025 124
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 123
The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease 103
The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease 103
Rheumatoid Arthritis and Cardiovascular Risk: Retrospective Matched-Cohort Analysis Based on the RECORD Study of the Italian Society for Rheumatology 99
Risk of hospitalisation for serious bacterial infections in patients with rheumatoid arthritis treated with biologics. Analysis from the RECord linkage On Rheumatic Disease study of the Italian Society for Rheumatology 98
Use of Ultrasonography to Discriminate Psoriatic Arthritis from Fibromyalgia: A Post-Hoc Analysis of the ULISSE Study 97
Musculoskeletal ultrasound for treating rheumatoid arthritis to target—a systematic literature review 96
Persistence of bDMARD therapy in Rheumatoid Arthritis after first-line TNF-inhibitor failure: the RECORD study of the Italian Society for Rheumatology 94
One year in review 2019: novelties in the treatment of rheumatoid arthritis 91
One year in review 2021: novelties in the treatment of rheumatoid arthritis 91
Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosus 87
Role of comorbidities on therapeutic persistence of biological agents in rheumatoid arthritis: results from the RECord-linkage On Rheumatic Disease study on administrative healthcare databases 85
Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage 80
One year in review 2020: novelties in the treatment of rheumatoid arthritis 75
SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study 74
Pulmonary arterial hypertension in systemic lupus erythematosus: identification of risk factors and haemodynamics characteristics in a multicentre retrospective cohort 67
Switch from Intravenous to Subcutaneous Formulation of Tocilizumab in Rheumatoid Arthritis: Retrospective Cohort Analysis and Systematic Literature Review 60
Systemic lupus erythematosus: one year in review 2026 58
Efficacy of Belimumab on Different Joint and Skin Manifestations of Systemic Lupus Erythematosus: Real-Life Data from a New Multicentric, Nationwide Italian Cohort (BeRLiSS-JS 2.0) 58
Role of musculoskeletal ultrasound in diagnosing and managing chronic inflammatory arthritis in overweight and obese patients: a narrative review 56
Early antiproteinuric effect of voclosporin in patients with lupus nephritis in a real-life setting: preliminary results from the VoRLiSS (Voclosporin in Real Life Setting Study) experience 49
Ultrasound for assessing disease activity and structural damage in psoriatic arthritis: the UPsA scores from a multicentre study by the Italian Society of Rheumatology 44
Assessing the sensitivity and the clinical impact of the 2023 ACR/EULAR classification criteria in Obstetric Antiphospholid Syndrome: findings from a multicenter Italian cohort with a long-term follow-up 29
Distinct pattern of comorbidities hinders treatment target attainment in SLE through persistent disease activity and delayed glucocorticoid tapering: longitudinal data from a multicentre cohort study 28
Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study 24
Shaping rheumatoid arthritis treatment: Clinical and demographic drivers of tsDMARDs versus bDMARDs prescription post-EMA pronouncement on JAK inhibitors. Insights from the AMBI-RA study 23
Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohort 21
Glucagon-like peptide-1 receptor agonists in psoriasis and psoriatic arthritis: emerging evidence and future research opportunities. 14
Voclosporin for the treatment of lupus nephritis flares in patients with inadequate response to mycophenolate mofetil and belimumab: a case series 7
A data-driven, weighted flare score that accurately predicts organ damage in systemic lupus erythematosus 6
Totale 10.179
Categoria #
all - tutte 43.980
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 404
Totale 44.384


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022235 0 34 10 11 10 6 29 21 16 8 14 76
2022/2023245 26 32 15 18 39 17 6 21 27 4 20 20
2023/2024610 21 23 13 8 56 6 9 18 25 140 115 176
2024/20252.172 82 150 200 140 222 252 96 110 343 195 226 156
2025/20265.760 431 210 622 498 784 291 618 331 508 618 521 328
2026/2027668 454 214 0 0 0 0 0 0 0 0 0 0
Totale 10.179